Address
OrbiMed Advisors LLC
767 Third Avenue
30th Floor
New York, NY 10017
United States
Phone
Website
Recent investment activity
KANDO id: 29979
Corporate information
Founders
Official name
OrbiMed Advisors Limited Liability Company
Registration country
Company type
American investment firm focused on making public and private investments in the healthcare and biotechnology industries.Overview
OrbiMed invests globally across the healthcare industry, from start-ups to large multinational corporations, through a range of private equity funds, public equity funds, and royalty/credit funds. OrbiMed seeks to be a capital provider of choice, providing tailored financing solutions and extensive global team resources to help build world-class healthcare companies. OrbiMed’s team of over 100 professionals is based in New York City, San Francisco, Shanghai, Hong Kong, Mumbai, Herzliya, and other key global markets.
Funding rounds
Investment preferences
Investment focus themes
Top investment portfolio themes
Investment activity status
Active investor
Selected investments
Displaying 76 - 100 of 114Company | Profile | Country | Funding | ||
---|---|---|---|---|---|
DFINE Inc | Mission is to develop and market devices that treat vertebral compression | N/A | |||
Bonovo Orthopedics Inc | Provider of orthopedic products to the Chinese healthcare market. | N/A | |||
Ecron Acunova | Provides clinical development services. | N/A | |||
Singulex Inc | Provides immunoassay products and services. | N/A | |||
Roka Bioscience Inc | N/A | ||||
Response Biomedical Corp | Commercializing a new class of diagnostic. | N/A | |||
Good Start Genetics Inc | An innovative, molecular diagnostic company that has developed more accurate and comprehensive pre-pregnancy genetic tests | N/A | |||
Supernus Pharmaceuticals Inc | N/A | ||||
Shasun Pharmaceuticals Ltd | N/A | ||||
Keystone Heart Ltd | Developing cerebral protection devices. | N/A | |||
Rempex Pharmaceuticals Inc | Rempex Pharmaceuticals, Inc. is a San Diego-based pharmaceutical company. | N/A | |||
Relypsa Inc | Leads the discovery and development of new non-absorbed polymeric drugs | N/A | |||
Receptos Inc [] | N/A | ||||
Puma Biotechnology Inc | Biopharmaceutical company that acquires and develops innovative products. | N/A | |||
Pieris AG | Biopharmaceutical company. | N/A | |||
PharmAbcine Inc | Develops fully human therapeutic monoclonal antibody (mAb) | N/A | |||
Pacira Pharmaceuticals Inc | Acute care specialty pharmaceutical company. | N/A | |||
Methylgene Inc | Clinical-stage biopharmaceutical company that develops novel therapeutics for cancer and infectious disease. | N/A | |||
KIMS India | Asia's leading tertiary care hospitals. | N/A | |||
Adolor Corp | N/A | ||||
Kalidex Pharmaceuticals Inc | Providing next-generation anti-infective therapies to the marketplace | N/A | |||
Crown Bioscience Inc | A Contractor Research Operation (CRO) company based in Santa Clara, California and Beijing, China | N/A | |||
Anthera Pharmaceuticals Inc | N/A | ||||
Eddingpharm | Consumer pharmaceutical products | N/A | |||
Avalon Pharmaceuticals Inc | Biopharmaceutical company focused on the discovery and development of small molecule therapeutics for the treatment of cancer. | N/A |